Literature DB >> 12067747

Blockade of ionotropic receptor responses by progesterone in the ganglion cells of Aplysia.

Koichiro Takashima1, Satoshi Kawasaki, Shingo Kimura, Reiko Fujita, Kazuhiko Sasaki.   

Abstract

To compare nongenomic effects of progesterone on various receptor responses of neurons, Aplysia ganglion cells were pretreated with 30 microM progesterone for 5 min and various receptor responses were tested using a conventional voltage-clamp method. Progesterone reduced nicotinic receptor-activated Na(+)-currents, nicotinic receptor-activated Cl(-)-currents, gamma-aminobutyric acid receptor-activated Cl(-)-currents, and dopamine receptor-activated Na(+)-currents. These depressant effects are similar at two different agonist concentrations. On the other hand, progesterone affected neither muscarinic receptor-activated K(+)-currents nor dopamine receptor-activated K(+)-currents. The former four types of receptors are known to be ionotropic while the latter two types of receptors are known to be metabotropic. Therefore, progesterone selectively inhibited all the types of ionotropic receptor responses, presumably in a noncompetitive manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067747     DOI: 10.1016/s0168-0102(02)00024-x

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  2 in total

1.  Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers.

Authors:  Kelly P Cosgrove; Irina Esterlis; Sherry A McKee; Frederic Bois; John P Seibyl; Carolyn M Mazure; Suchitra Krishnan-Sarin; Julie K Staley; Marina R Picciotto; Stephanie S O'Malley
Journal:  Arch Gen Psychiatry       Date:  2012-04

2.  Response to nicotine following overnight smoking abstinence during short-term progesterone treatment in women.

Authors:  Sharon Allen; Ashley Petersen; Katherine Harrison; Nicole Tosun; Jacquelyn Cameron
Journal:  Exp Clin Psychopharmacol       Date:  2019-08-29       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.